Barrow Neurological Institute has initiated a $50 million effort, supported by the single largest research grant in the history of brain tumor research, to seek a cure for the deadliest form of brain cancer. Funding from The Ben and Catherine Ivy Foundation will be used to dramatically accelerate drug discovery and clinical testing for glioblastoma […]Continue Reading ...
Triple-negative breast cancer, also known as TNBC, is an invasive, aggressive and hard-to-treat beast. The cancer cells lack the expression of three cell surface molecules that are common targets for therapy, and the prognosis for patients can be poor. It’s left its mark on my own family, but we are far from the only ones affected. […]Continue Reading ...
A new diagnostic tool is expected to result in better treatment of cancer that is difficult to diagnose. The tool was developed by cancer researchers at Sahlgrenska Academy and doctors at the Sahlgrenska University Hospital, Sweden. Their study, which has been published in JCO Precision Oncology, started with a single cancer patient. “We believe that […]Continue Reading ...
Researchers have discovered a link between certain changes in the genome of a tumor and increased chances of death across multiple types of cancer. Their findings, published in eLife, suggest the percentage of a tumor’s genome with alterations in copy number (or ‘copy number alteration’; CNA) is associated with mortality in a range of cancers. […]Continue Reading ...
Cancer researchers struggle to identify tumor cells that are interspersed within nonmalignant tissues because tumor cells exploit the tissue environment and monopolize available resources to continue growing. Researchers attribute cancer cell’s ability to use cell signaling and metabolic pathways that override normal cell growth restrictions to complicated chemical exchanges between tissue and tumor cells. A […]Continue Reading ...
Bottom Line: An evolutionary model utilizing serial blood samples from patients with advanced colorectal cancer treated with anti-EGFR therapies in a phase II trial could predict personalized waiting time for progression. Journal in Which the Study was Published: Cancer Discovery, a journal of the American Association for Cancer Research Authors: Co-senior authors Andrea Sottoriva, PhD, […]Continue Reading ...
A promising new study conducted by Australian and American researchers suggests that it may be possible to live with advanced breast cancer and not be diagnosed with metastasis. Image Credit: royaltystockphoto / Shutterstock As reported in the journal Nature Cell Biology, a study involving animals and people showed that in advanced breast cancer, the primary […]Continue Reading ...
Aug 22 2018 Childhood Brain Tumor Treatment Impairs New Memory Formation Young people who received radiation therapy for the most common pediatric brain tumor struggle to create new memories about specific events, according to a study of children and adolescents published in JNeurosci. Their ability to recall events prior to treatment, however, remains intact. Although […]Continue Reading ...
Researchers at The University of Texas MD Anderson Cancer Center have shown how BRCA-associated protein 1 (BAP1) serves as a tumor suppressor gene in kidney, eye, bile duct, mesothelioma and other cancers by regulating a form of cell death called ferroptosis, opening up a potential new area of therapy research. Findings from the study, led […]Continue Reading ...
Killer T cells surround a cancer cell. Credit: NIH Researchers have discovered a link between certain changes in the genome of a tumor and increased chances of death across multiple types of cancer. Their findings, published in eLife, suggest the percentage of a tumor’s genome with alterations in copy number (or ‘copy number alteration’; CNA) […]Continue Reading ...
Important research by Barrow Neurological Institute neurosurgeons and University of Washington (UW) scientists on novel imaging technology for malignant brain tumors was published in the August issue of the Nature journal, Scientific Reports. The research was conducted by Drs. Mark Preul and Evgenii Belykh at the Barrow Neurological Institute Neurosurgery Research Laboratory along with Drs. […]Continue Reading ...
An aggressive brain tumor (glioblastoma), illustrated based on magnetic resonance data. Credit: Karl-Heinz Nenning Glioblastoma is a highly aggressive brain cancer that predominantly affects people in their 50s, 60s and 70s. Even under the best available care, half of the patients die within one year after diagnosis, and very few live on for more than […]Continue Reading ...
A research team from Roswell Park Comprehensive Cancer Center has discovered a way to use computed tomography (CT) imaging to assess kidney tumors that test positive for the biomarker CD117 and accurately determine – before surgery – whether the tumor is benign or malignant. The findings have been published in Clinical Cancer Research, a journal […]Continue Reading ...
A study published in The Lancet Oncology establishes for the first time that artificial intelligence can process medical images to extract biological and clinical information. By designing an algorithm and developing it to analyze CT scan images, medical researchers at Gustave Roussy, CentraleSupélec, Inserm, Paris-Sud University and TheraPanacea (spin-off from CentraleSupélec specializing in artificial intelligence […]Continue Reading ...
What are tumor marker tests? These tests look for tumor markers, sometimes called cancer markers, in the blood, urine, or body tissues. Tumor markers are substances made by cancer cells or by normal cells in response to cancer in the body. Some tumor markers are specific to one type of cancer. Others can be found […]Continue Reading ...
- Novel deep learning drug discovery platform gets £1 million innovation boost
- Sensor array may detect de novo Parkinson’s disease in breath
- A roadmap for the future of electronic health records
- Surprising research showing peptide adaptability may pave way to develop immunotherapies
- Amyloid β protein makes comeback as therapeutic target for Alzheimer’s disease
- Alcon expands its global support of eye care professionals through Alcon Experience Academy
- Study gives new insights into how cells leverage GPCRs to control inflammation
- Automatic relevance detection in ophthalmic surgery videos
- UNIST to accelerate discovery, development of new medicines for incurable diseases
- Novel clinical trial to examine cannabis as potential treatment for essential tremor
- Salsa dancers have lower injury rates than Spanish, aerobic or Zumba dancers
- Bristol-Myers Squibb’s Novel, Oral, Selective TYK2 Inhibitor Delivered Significant Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis in Phase 2 Trial
- Can work stress contribute to Parkinson’s disease risk?
- Global Climate Action Summit: A focus on kids and climate
- Vitamin D may reduce breast cancer mortality in women with lower BMI
- Targeted Lung Denervation procedure significantly reduces COPD problems
- FDA-approved ‘safe’ daily BPA exposure may contribute to insulin resistance
- Research finds physical connection between the brain’s fluid reservoirs and meningeal lymphatics
- UCalgary study could help physicians make better treatment decisions for stroke
- Biomedical review finds failure rates in some surgical mesh treatments to be unacceptably high